ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:10 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 176
Drug details and screening numbers
Drug Name: IPA-3
Drug ID: 176
Synonyms: IPA-3
Brand name:
Target: PAK1, PAK2, PAK3
Number of cell lines screened: 874
Screening concentration range(s): 0.125 to 32 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a197 |
loss_cnaPANCAN368 |
176 |
1 |
1 |
IPA-3 |
PAK1, PAK2, PAK3 |
108 |
763 |
3.47 |
3.96 |
4.73 |
0.769 |
0.48 |
0.48 |
0.5 . |
8.1e-05 |
3.61e-24 |
3.63e-01 |
6.8 |
All-tests volcano plot